Hansa Biopharma AB (publ)
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 24H.F | CABA | IMUX | KYTX | DSGN | AUTL | |
|---|---|---|---|---|---|---|
| Market cap | 333.91M | 261.95M | 106.15M | 364.26M | 667.75M | 439.19M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | -1.3 | -3.2 | -1.9 | -6.6 | -2.6 |
| Price/book | -0.5 | 1.2 | 0.8 | 2.2 | 3.3 | 5.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +10.05% | −34.29% | −6.08% | −9.45% | +100.72% | +7.10% |
| Today | −0.06% | −4.04% | +4.99% | −2.48% | −3.87% | −0.60% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All 24H.F news ›Hansa Biopharma AB (publ) (OTCMKTS:HNSBF) Sees Large Increase in Short Interest
Hansa Biopharma AB (publ) (OTCMKTS:HNSBF – Get Free Report) saw a significant increase in short interest in the month of September. As of September 30th, there was short interest totaling 93,732 shares, an increase of 264.3% from the…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
defenseworld.net1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.